| Jessica W Coker, CRNA | |
|
509 Biltmore Ave, Asheville, NC 28801-4601 | |
| (828) 213-2325 | |
| Not Available |
| Full Name | Jessica W Coker |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 509 Biltmore Ave, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205202371 | NPI | - | NPPES |
| 7100395390 | Medicaid | KY | |
| 201342820A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 290833 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gi Anesthesia Of Georgia Llc | 0446516769 | 95 |
| Greater Atlanta Anesthesia, Llc | 7315264645 | 12 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Concordia Anesthesiology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619296464 PECOS PAC ID: 8325172885 Enrollment ID: O20100819000220 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Atlanta Hand Specialist Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1285912923 PECOS PAC ID: 5890952410 Enrollment ID: O20120208000844 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Ahs Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316214604 PECOS PAC ID: 7911169925 Enrollment ID: O20120508000359 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Atlanta Anesthesia Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487928370 PECOS PAC ID: 4486818093 Enrollment ID: O20120612000168 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Gastroenterology Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942563242 PECOS PAC ID: 3779730080 Enrollment ID: O20120821000929 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Ahs Surgery Center Canton, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1225457948 PECOS PAC ID: 6103043377 Enrollment ID: O20140812000706 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Greater Atlanta Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285043158 PECOS PAC ID: 7315264645 Enrollment ID: O20150326000819 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Carpus Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1568864452 PECOS PAC ID: 4688994387 Enrollment ID: O20150520002165 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Coastal Ambulatory Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750753786 PECOS PAC ID: 1052613023 Enrollment ID: O20160107001775 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Radius Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1215302906 PECOS PAC ID: 1456644244 Enrollment ID: O20160802000541 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Ulna Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1881147965 PECOS PAC ID: 8729356977 Enrollment ID: O20170613001165 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Gi Anesthesia Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326569187 PECOS PAC ID: 0446516769 Enrollment ID: O20171102000283 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Anesthesia Dynamics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073001012 PECOS PAC ID: 3779832530 Enrollment ID: O20200508002106 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Entity Name | Lunate Surgery Center |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1932709490 PECOS PAC ID: 8022427681 Enrollment ID: O20210511002620 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica W Coker, CRNA 509 Biltmore Ave, Asheville, NC 28801-4601 Ph: (828) 213-2325 | Jessica W Coker, CRNA 509 Biltmore Ave, Asheville, NC 28801-4601 Ph: (828) 213-2325 |
News Archive
Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.
A new study demonstrates the potential effectiveness of treating tumors by combining agents that damage DNA with a drug that sensitizes cancer cells to these agents.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).
› Verified 3 days ago
Bradley Richard Gleckler, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1111 | |
Kenneth B Walker, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 76 Peachtree Rd, Suite 300, Asheville, NC 28803 Phone: 828-254-1969 Fax: 828-254-4611 | |
Mr. Timothy Whalen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 76 Peachtree Road, Suite 300, Asheville, NC 28803 Phone: 828-254-1969 Fax: 828-274-7407 | |
Emma Greear Autry, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-2325 | |
Angela Michelle Simmons, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 76 Peachtree Rd, Suite 300, Asheville, NC 28803 Phone: 828-254-1969 Fax: 828-254-4611 | |
Tamara Ann Matejka, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 76 Peachtree Road, Suite 300, Asheville, NC 28803 Phone: 828-274-3477 Fax: 828-274-7407 | |
Michael Hector, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1111 |